On October 5, 2016, the Federal Trade Commission (FTC) settled its case with Supple, LLC over certain advertising claims regarding its Supple joint supplement. Between 2011 and 2015, the company advertised (via social media, radio, and in-person pitches) that the supplement was scientifically proven to provide complete relief from chronic and severe joint pain stemming